Tandem Diabetes Care | TNDM - Interest Expense On Debt


Tandem Diabetes Care reported $1.15B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Accuray USD 2.88M 72K Dec/2024
Align Technology USD 16.04M 14.04M Dec/2025
AtriCure USD 1.37M 42K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 90M 0 Mar/2026
Cooper Companies USD 20.9M 1.5M Mar/2026
Dexcom USD 4.2M 500K Dec/2025
Edwards Lifesciences USD 35.9M 2.7M Dec/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Globus Medical USD 5.44B 5.44B Mar/2026
ICU Medical USD 20.64M 21.39M Dec/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 14.7M 5.5M Mar/2026
Integra LifeSciences USD 22.46M 1.21M Mar/2026
Intuitive Surgical USD 20.11B 58.39B Mar/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 6.53M 162K Mar/2026
Orthofix International 4.68M 731K Sep/2025
Roche Holding CHF 304M 7.5M Jun/2025
Stryker USD 46.29B 45.68B Mar/2026
Tandem Diabetes Care USD 1.15B 1.15B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026